Used as a contrast agent in magnetic resonance imaging (MRI), Gadoteridol enhances the visibility of internal body structures by improving the contrast in images. It is particularly effective in detecting abnormalities in the central nervous system, such as tumors, inflammation, and blood-brain barrier disruptions. Due to its high stability and low toxicity, it is well-tolerated in clinical settings and is administered intravenously to provide clearer and more detailed MRI scans. Its non-ionic nature contributes to a favorable safety profile, making it suitable for a wide range of patients, including those with renal impairment when used with caution.